Skip to Content

Kirin Holdings Co Ltd

2503: XTKS (JPN)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
JPY 7,388.00XqfwnmKtzlnxr

Kirin’s Domestic Brewery Reforms Bearing Fruit; Awaiting Myanmar Issue To Be Resolved

Business Strategy and Outlook

Kirin is stepping up investment to transform itself into a wellness specialist over the long run. The secular volume decline in the domestic beer market has prompted Kirin to seek new growth avenues, of which it identifies wellness leveraging its pharmaceutical know-how and beverage resources as the third growth pillar. Meanwhile, margin expansion of the cash cow brewery business combined with overseas growth of the pharmaceutical sales will bolster mid-term profits. Kirin is pining hopes on the underpenetrated craft beer to invigorate the torpid beer consumption at home.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of 2503 so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center